Table 1 Baseline demographic and clinical characteristics of the participants
Group 1 (n = 9) | Group 2 (n = 9) | |
|---|---|---|
Sex (Men/Women) | (5/4) | (5/4) |
Age (Mean ± SD) (years) | 68.7 ± 3.1 | 70.3 ± 4.3 |
Disease duration (Mean ± SD) (years) | 1.4 ± 0.6 | 1.3 ± 0.4 |
Duration of levodopa treatment (Mean ± SD) (years) | 0.7 ± 0.3 | 0.8 ± 0.5 |